Two Sigma Investments’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Two Sigma Investments’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-119,070	Closed	-$371K	–	3319
2023 Q2	$371K	Buy	119,070 +97,279	+446%	+$289K	﹤0.01%	2448
2023 Q1	$55.8K	Buy	+21,791	New	+$45K	﹤0.01%	2741
2022 Q4	–	Sell	-36,639	Closed	-$64K	–	3143
2022 Q3	$64K	Sell	36,639 -21,686	-37%	-$30.7K	﹤0.01%	2291
2022 Q2	$76K	Sell	58,325 -101,373	-63%	-$174K	﹤0.01%	2301
2022 Q1	$380K	Buy	+159,698	New	+$416K	﹤0.01%	2135
2021 Q2	–	Sell	-18,894	Closed	-$167K	–	4691
2021 Q1	$167K	Buy	18,894 +4,016	+27%	+$44.1K	﹤0.01%	3656
2020 Q4	$152K	Buy	+14,878	New	+$163K	﹤0.01%	3162

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Investments's GRTX Position: Q3 2023 in Review

Two Sigma Investments sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 119,070 shares — an estimated $371K sold.

Two Sigma Investments first reported a position in GRTX in Q4 2020 and held it in 7 quarters. The position peaked at $380K in Q1 2022. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

Two Sigma Investments reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 119,070 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $371K.
Two Sigma Investments first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Two Sigma Investments's Galera Therapeutics, Inc. Common Stock position peaked at $380K in Q1 2022.
38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.